Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement.
about
Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.Recent advances on diagnosis and management of childhood asthma and food allergiesThe Danish National Database for Asthma: establishing clinical quality indicatorsAllergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinSublingual immunotherapy: World Allergy Organization position paper 2013 update.Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.Diseases of the nose and paranasal sinuses in child.The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practiceAuthorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written.Optimal management of allergic rhinitis.Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis.Regulatory aspects of allergen-specific immunotherapy: europe sets the scene for a global approach.Comparative analysis of allergic rhinitis in children and adults.Specific immunotherapy-indications and mode of action.A comparison of immunotherapy delivery methods for allergen immunotherapy.Recombinant allergen-based provocation testing.Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology.Pediatric allergic rhinitis and asthma: can the march be halted?Allergology in Europe, the blueprint.Immunotherapy - risk/benefit in food allergy.Immunotherapy in allergy and cellular tests: state of art.Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.Contributing factors to the development of childhood asthma: working toward risk minimization.Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.Efficacy and safety of sublingual immunotherapy in children.Allergen immunotherapy in allergic rhinitis: current use and future trends.Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.Asthma and allergic rhinitis in childhood: what's new.Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice.The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.Course of respiratory allergy by treatment strategy based on German routine data.Perspectives in allergen immunotherapy: 2017 and beyond.The history of pediatric allergy in Europe - from a working group to ESPACI and SP-EAACI.Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.The natural course of allergic rhinitis: a 32-year follow-up study.
P2860
Q26775905-C4AEF1D7-82AF-4000-B071-9E26E5373304Q26827150-831FD1CE-4582-484E-959B-7D1385783745Q28074257-EA55D737-38FB-4079-A2D5-9813E8BEE2D2Q28077951-9C8F8C8F-D9F0-4D55-8C11-74F1D4C3F3ECQ30440195-A852B6F6-3120-4D15-AE6B-F539D22E9AFCQ34398080-408BF658-D3AC-4766-B46C-9C37F0DCD83AQ34751071-66A01FCC-FBCD-4CE4-811D-966CD9A83817Q35052674-5025D6F1-CB2B-4B5A-A86D-4432DB127FC2Q35777063-D28D07A2-3943-4A2F-BDAB-6CE88F69B331Q35888881-77E17FB4-711F-44CC-B76C-3D84A7D9F1CDQ36078136-04C0B438-0C39-471A-B27F-5DED78FD361FQ36811415-4DDC46DD-1725-4DE8-810A-11FDD3DD90F8Q36834860-39D4CA06-1117-4551-9A8B-5C4AC37554F6Q38068337-898ACD9C-ADB9-4989-836D-79032E433A24Q38093578-22C250C8-60DB-49A0-AB62-ACAC83FB5C0EQ38103286-C3A7192E-FC0C-4A49-A442-56525AF8869FQ38127011-4E33B8F0-71AA-49D6-B5A1-96A870B5D64CQ38129435-0A5B941F-86BA-4194-A9F2-BF3007FF308CQ38129766-87C715EE-AB80-41DD-BA0B-7C344CF6E30BQ38140060-4712E422-4397-4558-B01B-8E8D53A2D671Q38151256-70BFE119-5A3E-4508-8F75-58A1E916BF3AQ38203380-A1858294-5F3F-4B64-8528-A3E6519E3F43Q38265953-5AC88ED8-E424-4EF6-86EC-5F7DAA7EA546Q38278145-D867BA4C-966C-48BE-93B8-2DAC65B1DA18Q38420848-5998ECE7-358E-4394-8414-1E7BD398C4E2Q38614896-F2424035-D79D-4AE5-B107-2591821B9AFDQ38615030-5B81A3FF-DD10-4AA6-BFDD-8AA11FF82058Q38680655-D264BBE5-1E26-4D33-A232-7E193A1D135DQ38765929-EFB564ED-1A20-48DE-A507-8BB04AF93676Q39012986-15F5C5BB-5E0D-4E63-9094-DFCC2A20015CQ39305632-6F402950-0251-4843-86C0-B2F1FE7BA076Q39380921-BD5544E8-9A47-4727-851E-D43BFD0A166DQ42365536-A67F9B32-2E1C-4676-9439-9D342CE428A0Q47700986-1AEB6809-84F6-480E-BA07-83BEF08BFA38Q48315051-90EC99AB-D467-438B-A614-66FE43310A0CQ51074147-C6BEB2E1-545B-4282-9BC6-5C5BB348142CQ54763271-827B14B1-F995-4A8F-9E1C-39F796EDB622
P2860
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Perspectives on allergen-speci ...... : an EAACI position statement.
@en
type
label
Perspectives on allergen-speci ...... : an EAACI position statement.
@en
prefLabel
Perspectives on allergen-speci ...... : an EAACI position statement.
@en
P2093
P2860
P1476
Perspectives on allergen-speci ...... : an EAACI position statement.
@en
P2093
B Niggemann
E Valovirta
European Academy of Allergy and Clinical Immunology
M A Calderon
P2860
P304
P356
10.1111/J.1399-3038.2012.01313.X
P577
2012-06-01T00:00:00Z